Regeneron Pharmaceuticals
REGN
#277
Rank
A$119.93 B
Marketcap
A$1,132
Share price
-0.14%
Change (1 day)
-2.62%
Change (1 year)

Market capitalization of Regeneron Pharmaceuticals (REGN)

Market cap: A$119.93 Billion

As of December 2025 Regeneron Pharmaceuticals has a market cap of A$119.93 Billion. This makes Regeneron Pharmaceuticals the world's 277th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regeneron Pharmaceuticals from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025A$119.93 B-4.71%
2024A$125.86 B-10.39%
2023A$140.44 B21.64%
2022A$115.46 B23.25%
2021A$93.67 B39.73%
2020A$67.04 B13.36%
2019A$59.14 B2.33%
2018A$57.79 B11.7%
2017A$51.73 B-3.67%
2016A$53.71 B-31.12%
2015A$77.98 B51.88%
2014A$51.34 B66.92%
2013A$30.76 B92.06%
2012A$16.01 B220.03%
2011A$5.00 B73.17%
2010A$2.89 B32.38%
2009A$2.18 B5.33%
2008A$2.07 B-4.84%
2007A$2.17 B30.81%
2006A$1.66 B35.77%
2005A$1.22 B84.48%
2004A$0.66 B-39.54%
2003A$1.09 B-24.79%
2002A$1.46 B-39.73%
2001A$2.42 B4.53%
2000A$2.32 B280.64%
1999A$0.60 B63.19%
1998A$0.37 B-8.08%
1997A$0.40 B-22.02%
1996A$0.52 B

End of Day market cap according to different sources

On Dec 17th, 2025 the market cap of Regeneron Pharmaceuticals was reported to be:

A$119.10 Billion
by Nasdaq info icon info icon
A$120.10 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
A$264.03 B 120.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$79.08 B-34.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$37.67 B-68.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$758.54 B 532.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$392.29 B 227.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$177.04 B 47.62%๐Ÿ‡ซ๐Ÿ‡ท France